Prof. Ali Mohammad Sharifi is a scholar with over 27 years of experience in Molecular Pharmacology at the Iran University of Medical Sciences and currently joined as a professor of regenerative Medicine in the Tissue Engineering Group at NOCERAL, department of Orthopedics Surgery, School of Medicine. He obtained his Ph.D. from the University of Glasgow in 1992 and in 2018, he further enriched his expertise by acquiring a Tissue Banking Diploma from the National University of Singapore. Throughout his career, Prof. Sharifi has undertaken international research, including working at McGill University in Canada and at Max Plank Institute in Germany. His research output includes over 100 publications in high-impact journals, along with several patented innovations. He has held various administrative and editorial roles in academia, and has served as a peer reviewer for numerous high-impact journals. His dedication to education is evident through his mentorship of undergraduate and postgraduate students, particularly Ph.D. candidates specializing in molecular medicine, tissue engineering, molecular pharmacology, and cell therapy.  Prof. Sharifi's research expertise involves the fields of cell therapy and regenerative Pharmacology, with a particular emphasis on translational medicine. His extensive body of work includes pioneering studies on pharmacological priming, therapeutic angiogenesis, and innovative strategies to enhance the effectiveness of stem cell therapy by manipulating HIF-1α stabilization, especially in the context of diabetes. Additionally, his research activities include bone and cartilage regeneration, employing a diverse array of strategies such as stem cells and biologically derived products like amniotic membrane extract and mesenchymal stem cell-derived secretome. He has also explored the potential of herbal agents in regenerative medicine.  His contributions extend to the development of custom-made bio-implants for addressing large bone defects and the design and production of various wound dressings, with a specific focus on diabetic wound healing. In recent times, Prof. Sharifi has harnessed the transformative power of CRISPR gene editing technology to combat synovial fibrosis induced by osteoarthritis. In summary, Professor Sharifi is an active scientist in the field of Molecular Pharmacology and Regenerative Medicine, exemplifying innovation, and dedication to advancing scientific knowledge for improvement of healthcare and human well-being.  

I am Husna. Hi! I am passionate about blockchain, corporate finance, and hiking.

Bibliography: Professor Dr Wan Haliza Abd. Majid (2021)   Dr Wan Haliza Abd. Majid graduated with Bachelor in Physics from University College of Wales, Aberystwyth, UK in 1988. Initially, she worked in the Physics department, University Malaya as a tutor from 1990-91 while she was completing her Master’s Degree. Upon completing her PhD in 1994 from the University of Sheffield (UK), she was attached to the Matriculation Centre (PASUM) from 1994-2000, University Malaya as a lecturer before transferring to the Physics Department in 2000. Currently, her research interest is related to pyroelectric and ferroelectric properties of organic materials, fabrication and device characterization of an organic light-emitting diode (OLED) and photo-sensing and signal processing of biomaterials, quantum dots, and their applications. She has participated in many seminars, workshops, conferences and community engagement projects related to the Physics education program. Her involvement in research led her to lead (Principle Investigator) various research grants since the year 2000 which include, Short Term Research Fund (PJP-UM), University Malaya Research Grant (UMRG), High Impact Research Grant (HIR-UM), Exploratory Research Grant Scheme (ERGS-MOHE), ScienceFund (MOSTI), Fundamental Research Grant Scheme (FRGS-MOHE) and Long Term Research Grant (LRGS-MOHE).  She has been invited as one of the panel reviewers/evaluators for various grants awarded by MOHE and MOSTI at the university and national level since 2012. Internationally, her involvement as one of the panel reviewers for the Slovak Research And Development Agency starts from the year 2016 until recently. Currently, she is the Head of Low Dimensional Materials Research Center (LDMRC) (since 2016), the Chief Editor of Malaysian Journal of Science (MJS) (since 2020), the Chairperson for MASS Chapter of University Malaya (since 2019) and Committee member for Institute of Physics (IFM) (since 2021). She was appointed as Deputy Dean of Research and Higher Degree at the Faculty of Science (2010-2014), Dean (2017-2019) and Deputy Dean (2016-2017) of Institute of Postgraduate Studies (IPS). She is committed to equipping graduates at the tertiary level with knowledge, technology and values that can be used to interact positively with society at large.